关注
Florian Malard
Florian Malard
Post-doctoral fellow, ARNA INSERM U1212, Bordeaux, France
在 inserm.fr 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The human O-GlcNAcome database and meta-analysis
E Wulff-Fuentes, RR Berendt, L Massman, L Danner, F Malard, J Vora, ...
Scientific data 8 (1), 25, 2021
1842021
Principles and correction of 5’-splice site selection
F Malard, CD Mackereth, S Campagne
RNA biology 19 (1), 943-960, 2022
172022
An in vitro reconstituted U1 snRNP allows the study of the disordered regions of the particle and the interactions with proteins and ligands
S Campagne, T de Vries, F Malard, P Afanasyev, G Dorn, E Dedic, ...
Nucleic acids research 49 (11), e63-e63, 2021
152021
Structural insights into TCTP and its interactions with ligands and proteins
N Assrir, F Malard, E Lescop
TCTP/tpt1-Remodeling Signaling from Stem Cell to Disease, 9-46, 2017
112017
Automatization and self-maintenance of the O-GlcNAcome catalog: a smart scientific database
F Malard, E Wulff-Fuentes, RR Berendt, G Didier, S Olivier-Van Stichelen
Database 2021, baab039, 2021
102021
Conformational ensemble and biological role of the TCTP intrinsically disordered region: influence of calcium and phosphorylation
F Malard, N Assrir, M Alami, S Messaoudi, E Lescop, T Ha-Duong
Journal of molecular biology 430 (11), 1621-1639, 2018
102018
Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39
S Campagne, D Jutzi, F Malard, M Matoga, K Romane, M Feldmuller, ...
Nature communications 14 (1), 5366, 2023
82023
Revisiting the molecular interactions between the tumor protein TCTP and the drugs sertraline/thioridazine
F Malard, E Jacquet, N Nhiri, C Sizun, A Chabrier, S Messaoudi, J Dejeu, ...
ChemMedChem 17 (1), e202100528, 2022
82022
Drimane Derivatives as the First Examples of Covalent BH3 Mimetics that Target MCL‐1
F Daressy, F Malard, L Seguy, V Guérineau, C Apel, V Dumontet, ...
ChemMedChem 16 (11), 1789-1798, 2021
72021
The diversity of splicing modifiers acting on A-1 bulged 5′-splice sites reveals rules for rational drug design
F Malard, AC Wolter, J Marquevielle, E Morvan, A Ecoutin, SH Rüdisser, ...
Nucleic Acids Research 52 (8), 4124-4136, 2024
52024
Studying the O-GlcNAcome of human placentas using banked tissue samples
S Luna, F Malard, M Pereckas, M Aoki, K Aoki, S Olivier-Van Stichelen
Glycobiology 34 (4), cwae005, 2024
42024
Non-Nutritive Sweeteners Acesulfame Potassium and Sucralose Are Competitive Inhibitors of the Human P-glycoprotein/Multidrug Resistance Protein 1 (PGP/MDR1)
L Danner, F Malard, R Valdes, S Olivier-Van Stichelen
Nutrients 15 (5), 1118, 2023
42023
Find out if your protein is O‐GlcNAc modified: The O‐GlcNAc database
S Olivier‐Van Stichelen, F Malard, R Berendt, E Wulff‐Fuentes, L Danner
The FASEB Journal 36, 2022
42022
EpyNN: Educational python for Neural Networks
F Malard, L Danner, E Rouzies, JG Meyer, E Lescop, ...
SoftwareX 19, 101140, 2022
22022
Molecular Basis for the Calcium-Dependent Activation of the Ribonuclease EndoU
F Malard, K Dias, M Baudy, S Thore, B Vialet, P Barthélémy, S Fribourg, ...
12024
Small molecules modulating RNA splicing: a review of targets and future perspectives
L Bouton, A Ecoutin, F Malard, S Campagne
RSC Medicinal Chemistry, 2024
12024
Structural transitions in TCTP tumor protein upon binding to the anti-apoptotic protein family member Mcl-1
F Malard, C Sizun, A Thureau, L Carlier, E Lescop
Journal of Biological Chemistry 299 (7), 2023
12023
The O-GlcNAc database: introducing new features and tools developed from community feedback
F Malard, L Massman, S Campagne, S Olivier-Van Stichelen
Analytical and Bioanalytical Chemistry, 1-6, 2024
2024
1H, 13C and 15N backbone resonance assignment of the calcium-activated EndoU endoribonuclease
F Malard, FV Karginov, S Campagne
Biomolecular NMR Assignments, 1-5, 2024
2024
Unintentional family poisoning with a chocolate bar with Psilocybe cubensis inside: a case report
C Adamski, JA Vaucel, C Paradis, C Brunet, A Nardon, A Courtois, ...
Toxicologie Analytique et Clinique, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20